[NBY] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
11-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 78.81%
YoY- -1,466.67%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 2,631 3,124 2,629 1,807 1,892 1,491 2,947 -1.87%
PBT -3,090 -1,739 -111 -1,518 -1,582 -4,188 -2,150 6.22%
Tax 124 5 -2,271 0 -139 1 -214 -
NP -3,214 -1,739 -111 -1,518 -1,582 -4,189 -2,150 6.92%
Tax Rate - - - - - - - -
Total Cost 5,845 4,863 2,740 3,325 3,474 5,680 5,097 2.30%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -122.16 -55.67 -4.22 -84.01 -83.62 -280.95 -72.96 8.96%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -4.92 -23.13 -2.71 -44.51 -69.27 -300.22 -160.53 -44.02%
EPS Diluted -4.92 -23.13 -2.71 -44.51 -69.27 -300.22 -173.72 -44.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.